These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16938195)

  • 21. Cost-effectiveness of physiologic pacing: results of the Canadian Health Economic Assessment of Physiologic Pacing.
    O'Brien BJ; Blackhouse G; Goeree R; Healey JS; Roberts RS; Gent M; Connolly SJ
    Heart Rhythm; 2005 Mar; 2(3):270-5. PubMed ID: 15851317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term survival of chosen atrial-based pacing modalities.
    Irwin M; Carbol B; Senaratne M; Gulamhusein S
    Pacing Clin Electrophysiol; 1996 Nov; 19(11 Pt 2):1796-8. PubMed ID: 8945043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Doppler ultrasound measurement of cardiac output in patients with physiologic pacemakers. Effects of left ventricular function and retrograde ventriculoatrial conduction.
    Stewart WJ; Dicola VC; Harthorne JW; Gillam LD; Weyman AE
    Am J Cardiol; 1984 Aug; 54(3):308-12. PubMed ID: 6465010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An update on clinical trials in pacing: is dual chamber pacing better?
    Hussein SJ; Hennekens CH; Lamas GA
    Curr Opin Cardiol; 2004 Jan; 19(1):12-8. PubMed ID: 14688628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single chamber ventricular compared with dual chamber pacing: a review.
    Wong GC; Hadjis T
    Can J Cardiol; 2002 Mar; 18(3):301-7. PubMed ID: 11907619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atrial arrhythmia management with sensor controlled atrial refractory period and automatic mode switching in patients with minute ventilation sensing dual chamber rate adaptive pacemakers.
    Lau CP; Tai YT; Fong PC; Li JP; Chung FL
    Pacing Clin Electrophysiol; 1992 Oct; 15(10 Pt 1):1504-14. PubMed ID: 1383962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Support of spontaneous atrioventricular conduction in patients with DDR(R) pacemakers: effectiveness and safety].
    Himmrich E; Krämer LI; Fischer W; Dörr T; Reinecke H;
    Herz; 2001 Feb; 26(1):69-74. PubMed ID: 11258112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [DDD versus DDDR pacemaker stimulation: comparison of cardiopulmonary performance, incidence of atrial arrhythmias and quality of life].
    Epperlein S; Kreft A; Siegert V; Liebrich A; Himmrich E; Treese N
    Z Kardiol; 1996 Apr; 85(4):226-36. PubMed ID: 8693765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Current pacemaker treatment and technology].
    Candinas R; Bauersfeld U
    Praxis (Bern 1994); 1996 May; 85(20):663-70. PubMed ID: 8685558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of internal audit on pacemaker prescription and the immediate costs of pacing in the northern region: towards implementation of the recommendations of the British Pacing and Electrophysiology Group.
    Mounsey JP; Ray SG; Griffith MJ; Gold RG; Bexton RS
    Br Heart J; 1994 Apr; 71(4):395-8. PubMed ID: 8198896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of permanent pacing to prevent atrial fibrillation: science advisory from the American Heart Association Council on Clinical Cardiology (Subcommittee on Electrocardiography and Arrhythmias) and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the Heart Rhythm Society.
    Knight BP; Gersh BJ; Carlson MD; Friedman PA; McNamara RL; Strickberger SA; Tse HF; Waldo AL; ; ; ;
    Circulation; 2005 Jan; 111(2):240-3. PubMed ID: 15657388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pacemaker implantation and quality of life in the Mode Selection Trial (MOST).
    Fleischmann KE; Orav EJ; Lamas GA; Mangione CM; Schron E; Lee KL; Goldman L
    Heart Rhythm; 2006 Jun; 3(6):653-9. PubMed ID: 16731465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Benefits and limits of single chamber atrial pacing with adaptive rate].
    Pouillot C; Mabo P; Lelong B; Cazeau S; Paillard F; de Place C; Daubert JC
    Arch Mal Coeur Vaiss; 1990 Nov; 83(12):1833-42. PubMed ID: 2125194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pacemaker mode selection: the evidence from randomized trials.
    Montanez A; Hennekens CH; Zebede J; Lamas GA
    Pacing Clin Electrophysiol; 2003 May; 26(5):1270-82. PubMed ID: 12765457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual chamber pacing: how many patients remain in DDD mode over the long term?
    Ibrahim B; Sanderson JE; Wright B; Palmer R
    Br Heart J; 1995 Jul; 74(1):76-9. PubMed ID: 7662461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intermittent pacemaker syndrome: revision of VVI pacemaker to a new cardiac pacing mode for tachy-brady syndrome.
    McCormick DJ; Shuck JW; Ansinelli RA
    Pacing Clin Electrophysiol; 1987 Mar; 10(2):372-7. PubMed ID: 2437541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of atrioventricular asynchrony on platelet activation: implication of thromboembolism in paced patients.
    Lau CP; Tse HF; Cheng G
    Heart; 1997 Oct; 78(4):358-63. PubMed ID: 9404251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DDD pacing mode survival in patients with a dual-chamber pacemaker.
    Gross JN; Moser S; Benedek ZM; Andrews C; Furman S
    J Am Coll Cardiol; 1992 Jun; 19(7):1536-41. PubMed ID: 1593050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness of dual-chamber pacemaker therapy: does single lead VDD pacing reduce treatment costs of atrioventricular block?
    Wiegand UK; Potratz J; Bode F; Schreiber R; Bonnemeier H; Peters W; Katus HA
    Eur Heart J; 2001 Jan; 22(2):174-80. PubMed ID: 11161919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implantable cardiac arrhythmia devices--part I: pacemakers.
    Kusumoto FM; Goldschlager N
    Clin Cardiol; 2006 May; 29(5):189-94. PubMed ID: 16739389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.